Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001019687-05-001803
Filing Date
2005-07-01
Accepted
2005-07-01 19:51:27
Documents
1
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6961
  Complete submission text file 0001019687-05-001803.txt   8888
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Issuer) CIK: 0000704562 (see all company filings)

EIN.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address 14272 FRANKLIN AVE. TUSTIN CA 92780
SWARTZ ERIC S (Reporting) CIK: 0001244108 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17085 | Film No.: 05934472